Literature DB >> 22795796

Review of miR-200b and cancer chemosensitivity.

Bing Feng1, Rui Wang, Long-Bang Chen.   

Abstract

Chemoresistance remains a major obstacle to successful cancer treatment and leads to poor prognosis of the patients, yet the underlying mechanisms have not been fully understood. MicroRNAs (miRNAs) are non-coding small RNAs of 19-22 nucleotides which could negatively regulate gene expressions mainly through 3'-untranslated region (3'UTR) binding of target mRNAs. MiR-200 family (miR-200a, miR-200b, miR-200c, miR-141, and miR-429) is a cluster of miRNAs highly correlated with epithelial-mesenchymal transition (EMT), wherein miR-200b is identified as a critical regulator of tumor invasion, metastasis, and chemosensitivity. Recent advances of miR-200b dysregulation in tumor chemoresistance were summarized. Possible mechanisms and reversion strategies were also addressed.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22795796     DOI: 10.1016/j.biopha.2012.06.002

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  36 in total

1.  Conserved microRNA miR-8 blocks activation of the Toll pathway by upregulating Serpin 27 transcripts.

Authors:  Kayvan Etebari; Sassan Asgari
Journal:  RNA Biol       Date:  2013-06-20       Impact factor: 4.652

2.  Gα12 gep oncogene deregulation of p53-responsive microRNAs promotes epithelial-mesenchymal transition of hepatocellular carcinoma.

Authors:  Y M Yang; W H Lee; C G Lee; J An; E-S Kim; S H Kim; S-K Lee; C H Lee; D N Dhanasekaran; A Moon; S Hwang; S J Lee; J-W Park; K M Kim; S G Kim
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

Review 3.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

Review 4.  Entangling Relation of Micro RNA-let7, miRNA-200 and miRNA-125 with Various Cancers.

Authors:  Nosheen Masood; Zarrin Basharat; Tabeer Khan; Azra Yasmin
Journal:  Pathol Oncol Res       Date:  2017-01-09       Impact factor: 3.201

5.  MicroRNA-200b targets CREB1 and suppresses cell growth in human malignant glioma.

Authors:  Biao Peng; Su Hu; Qinming Jun; Dongdong Luo; Xun Zhang; Hailin Zhao; Dan Li
Journal:  Mol Cell Biochem       Date:  2013-03-30       Impact factor: 3.396

6.  Detection of microRNA-200b may predict the inhibitory effect of gefitinib on non-small cell lung cancer and its potential mechanism.

Authors:  Zhiwu Liu; Liqiong Yao; Bangyun Tan; Li Li; Baojin Chen
Journal:  Oncol Lett       Date:  2016-11-08       Impact factor: 2.967

Review 7.  MicroRNAs targeting prostate cancer stem cells.

Authors:  Yu-Xiang Fang; Yun-Li Chang; Wei-Qiang Gao
Journal:  Exp Biol Med (Maywood)       Date:  2015-05-12

8.  Predicting distant metastasis and chemoresistance using plasma miRNAs.

Authors:  Jianmei Chen; Weining Wang; Yangde Zhang; Yuxiang Chen; Tiehui Hu
Journal:  Med Oncol       Date:  2013-12-06       Impact factor: 3.064

Review 9.  Human antigen R and drug resistance in tumors.

Authors:  Fenghai Zhou; Fa Zhang; Chuan Zhou; Mengtian Liang; Zhonglin Cai; Haidi Lv; Wenjuan Li; Xupan Wei
Journal:  Invest New Drugs       Date:  2019-01-05       Impact factor: 3.850

10.  microRNA-204 modulates chemosensitivity and apoptosis of prostate cancer cells by targeting zinc-finger E-box-binding homeobox 1 (ZEB1).

Authors:  Guanlin Wu; Jian Wang; Guojun Chen; Xing Zhao
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.